WCT and DermaClose Join Synovis Micro Companies Alliance Today Wound Care Technologies, Inc. (WCT)—maker of the DermaClose® Continuous External Tissue Expander—announced it will join Synovis Micro Companies Alliance (MCA), a wholly owned subsidiary
FOR IMMEDIATE RELEASE Wound Care Technologies, Inc. Achieves ISO 13485 Certification. An important quality control criterion for international markets. Chanhassen, MN, February 16, 2017 – Wound Care Technologies, Inc. is pleased to have received
Come see us April 28th through 30th at the 11th Annual International San Francisco Orthopedic Trauma Course. We will be on 4th floor at the InterContinental San Francisco hotel on Howard Street. There will be approximately 475-525 attendees. The
Wound Care Technologies, Inc. is pleased to announce that the DermaClose Continuous External Tissue Expander is now available at The University of Alabama Birmingham Hospital (UAB) and its centers. After a thorough review of the clinical
PRESS RELEASE Contact: Paul Anderson WCT, Inc. CEO 952-937-2804 email@example.com FOR IMMEDIATE RELEASE WCT, INC. ANNOUNCES DERMACLOSE HAS BEEN USED IN OVER 15,000 CASES Eden Prairie, MN February 23, 2016 – Wound Care Technologies, Inc.
DermaClose is proud to announce the new commonly billed CPT codes for reimbursement, as well as a guide that showing the cost saving incurred with DermaClose vs NPWT, vessel loops, and skin grafting. Bottom line,
Duke University Medical Center has recently begun using DermaClose in their total ankle arthroplasty surgeries. Despite surgical improvements, the incidence of complications arising from TAA wound healing remains unacceptably high (up to 28%). These complications